Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Mice treated weekly with anti-GM-CSF mAb up to and including day 21 showed a trend towards slightly lower mean clinical scores (Supplementary Fig. 2c ); findings similar to mice treated on day 21 (Supplementary Fig. 2a ).

also in 53,322 other papers